MUPS (Multiple Unit Pellet System) Manufacturer

Author : Credo Life Science | Published On : 26 Mar 2026

Credo Life Science Pvt Ltd is a leading MUPS (Multiple Unit Pellet System) manufacturer, offering advanced drug delivery solutions that enhance bioavailability, improve patient compliance, and ensure consistent therapeutic performance. MUPS technology represents a significant advancement in pharmaceutical formulation, where multiple pellets are compressed into a single dosage form such as tablets or capsules.

This system provides several advantages over conventional single-unit dosage forms. By distributing the drug across multiple pellets, MUPS reduces the risk of dose dumping and ensures uniform drug release. It also allows for flexible formulation design, enabling the combination of immediate and sustained release profiles within the same dosage form.

Credolife utilizes cutting-edge pelletization and coating technologies to manufacture high-quality MUPS systems. Each pellet is engineered with precision to achieve desired release characteristics, whether immediate, sustained, or enteric. The manufacturing process is conducted under WHO-GMP compliant conditions, ensuring consistency, safety, and regulatory acceptance.

Benefits of MUPS Technology

Uniform drug distribution across multiple pellets
Reduced variability in drug absorption
Improved bioavailability
Enhanced patient safety and compliance
Flexibility in designing combination release profiles

Why Credolife for MUPS Manufacturing

Credolife’s strong R&D capabilities and advanced infrastructure enable the development of customized MUPS formulations tailored to specific therapeutic needs. The company works closely with pharmaceutical partners to deliver scalable, high-quality solutions that meet global standards.

With its commitment to innovation and excellence, Credolife continues to be a trusted name in MUPS manufacturing for global pharmaceutical markets.

👉 www.credolife.in